SKIN MANIFESTATIONS IN HIV/AIDS PATIENTS – OUR EXPERIENCE

Milena Djurovic, Bogdanka Andric, Milica Djurovic, Milos Bojic

Abstract


Objective: HIV/AIDS represents a significant public health issue since the number of cases is continuously on the rise. Even though contemporary medicine is rapidly developing, there is currently no effective cure for HIV. Mucocutaneous manifestations often represent the first recognized clinical manifestation. This study was carried out to note different presentations of HIV/AIDS on the skin.Material and Methods: The study included 150 patients who were hospitalized and have been confirmed as HIV positive either before the hospitalization or during the hospitalization.Results: Out of 150 patients, 50 of them had mucocutaneous presentations. Frequently, mucocutaneous lesions are the first manifestation of HIV/AIDS and a pointer toward setting up HIV/AIDS diagnosis. Moreover, the same patient was admitted more than once, because of a variety of skin manifestations.Conclusion: It was recognized that the greater the destruction of the immune system is, the more severe forms of mucocutaneous diseases occur. It is considered that cutaneous manifestations are rarely considered life-threatening in people living with HIV, but they can undoubtedly impair their quality of life.

Keywords


Mucocutaneous lesions, HIV/AIDS, skin, HIV pandemic, ART

Full Text:

PDF

References


Richman DD,Bozzette SA. The impact of the syncytium – inducinephenothype of human immunodeficiency virus on disease progression. J Infect Dis. 1994; 169(5): 968–74. doi: 10.1093/infdis/169.5.968.

https://doi.org/10.1093/infdis/169.5.968

O’Donovan D, Ariyoshi K, Milligan P, Ota M, Yamuah L, Sarge-Njie R, et al. Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates of HIV-1 and HIV-2 in The Gambia. MRC/Gambia Government/University College London Medical School working group on mother-child transmission of HIV. AIDS. 2000;14(4):441–8. doi: 10.1097/00002030-200003100-00019.

https://doi.org/10.1097/00002030-200003100-00019

Dean M, Carrington M, Winkler C, Huttley GA, Smith MW, Allikmets R, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science. 1996; 273(5283).1856-62. doi: 10.1126/science.273.5283.1856.

https://doi.org/10.1126/science.273.5283.1856

Ndour M, Sow PS, Coll-Seck AM, Badaine S, Ndour CT, Diakhate N et al. AIDS caused by HIV1 and HIV2 infection: are there clinical differences? Results of AIDS surveillance 1986–97 at Fann Hospital in Dakar, Senegal. Trop Med Int Health. 2000; 5(10): 687–91. doi: 10.1046/j.1365-3156.2000.00627.x.

https://doi.org/10.1046/j.1365-3156.2000.00627.x

Sharp PM, Hahn BH. Origins of HIV and the AIDS Pandemic. Cold Spring Harbor Perspect Med. 2011;1(1):a006841. doi: 10.1101/cshperspect.a006841.

https://doi.org/10.1101/cshperspect.a006841

Centers for Disease Control and Prevention. (2014) HIV/AIDS: Statistics Overview. Accessed at www.cdc.gov/hiv/statistics/basics/index.html on July 21.

Joint United Nations Programme on HIV/AIDS (UNAIDS); World Health Organization. AIDS epidemic update: December 2009. Geneva: Joint United Nations Programme on HIV/AIDS (UNAIDS); 2009.

https://doi.org/10.1093/oso/9780190672676.003.0014

Matsiyeuskaya VN, Tsyrkunov MV. Activation of blood T-cells in HIV/HCV co-infected patients. Sanamed. 2013; 8 (1): 11-8.

Moir S, Chun TW, Fauci AS. Pathogenic ,echanisms of HIV disease. Annu Rev Pathol. 2011; 6:223-48. doi: 10.1146/annurev-pathol-011110-130254.

https://doi.org/10.1146/annurev-pathol-011110-130254

Sullivan PS, Fideli U, Wall KM, Chomba E, Vwalika C, Kilembe W et al. Prevalence of seroconversion symptoms and relationship to set-point viral load: findings from a subtype C epidemic, 1995-2009. AIDS. 2012;26(2):175-84. doi: 10.1097/QAD.0b013e32834ed8c8.

https://doi.org/10.1097/qad.0b013e32834ed8c8

Tappuni AR. The global changing pattern of the oral manifestations of HIV. Oral Dis. 2020;26( Suppl 1):22-7. doi: 10.1111/odi.13469.

https://doi.org/10.1111/odi.13469

Munawwar A, Grupta S, Sharma SK, Singh S. Seroprevalence of HSV-1 and 2 in HIV-infected males with and without GUD: Study from a tertiary care setting of India. J Lab Physicians. 2018; 10(3):326-31. doi: 10.4103/JLP.JLP_7_18.

https://doi.org/10.4103/jlp.jlp_7_18

Kakitha R, Shanmugam S. Bullous pemphigoid-like presentation of disseminated Herpes Zoster: a case report. Indian J Dermatol. 2020;65(3):234-5. doi: 10.4103/ijd.IJD_337_18.

https://doi.org/10.4103/ijd.ijd_337_18

Perello R, Vergara A, Monclus E, Jimenez S, Montero M, Saubi N et al. Cytomegalovirus infection in HIV-infected patients in the era of combination antiretroviral therapy. BMC Infectious Diseases. 2019;19(1): 1030. doi: 10.1186/s12879-019-4643-6.

https://doi.org/10.1186/s12879-019-4643-6

Gaurkar SP, Pund PB, Dindore PR, Bhoi UY. Extensive molluscum contagiosum causing obstruction of vision in HIV-positive women. Indian Dermatol Online J. 2016 ;7(3):190-1. doi: 10.4103/2229-5178.182360.

https://doi.org/10.4103/2229-5178.182360

Clifford GM, Tully S, Franceschi S. Carcinogenicity of Human Papilloma virus (HPV) types in HIV-positive women: a meta-analysis from HPV infection to cervical cancer. Clin Infect Dis. 2017;64(9):1228-35. doi: 10.1093/cid/cix135.

https://doi.org/10.1093/cid/cix135

Patil S, Majumdar B, Sarode SC, Sarode GS, Awan KH. Oropharyngeal candidosis in HIV-infected patients-an update. Front Microbiol. 2018;9:980. doi: 10.3389/fmicb.2018.00980.

https://doi.org/10.3389/fmicb.2018.00980

Ali SY, Gajjala SR, Raj A. Study of the prevalence of dermatophytes among human immunodeficiency virus/AIDS patients in Shadan Institute of Medical Sciences and Teaching Hospital and Research Centre, Hyderabad, Telangana, India. Indian J Sex Transm Dis AIDS. 2018;39(2):98-101. doi: 10.4103/ijstd.IJSTD_103_16.

https://doi.org/10.4103/ijstd.ijstd_103_16

Tirado-Sánchez A, Bonifaz A, Montes de Oca-Sánchez G, Araiza-Santibañez J, Ponce-Olivera RM. Escabiosis costrosa en pacientes con infección por VIH/SIDA. Reporte de 15 casos [Crusted scabies in HIV/AIDS infected patients. Report of 15 cases]. Rev Med Inst Mex Seguro Soc. 2016 ;54(3):397-400.

Forrestel AK, Kovarik CL, Mosam A, Gupta D, Maurer TA, Micheletti RG. Diffuse HIV-associated seborrheic dermatitis – a case series. Int J STD AIDS. 2016; 27 (14):1342-5. doi: 10.1177/0956462416641816.

https://doi.org/10.1177/0956462416641816

Balaban M, Ioana Nedelcu R, Balmes G, Adela Todorovic T, Brinzea A, Nichita Let al. Bacillary angiomatosis triggered by severe trauma in a healthy Caucasian patient: A case report. Exp Ther Med. 2020;20(1):56-60. doi: 10.3892/etm.2019.8260.

https://doi.org/10.3892/etm.2019.8260

Curtiss P, Strazzulla LC, Friedman-Kien AE. An Update on Kaposi's Sarcoma: Epidemiology, Pathogenesis, and Treatment. Dermatol Ther (Heidelb). 2016;6(4):465-70. doi: 10.1007/s13555-016-0152-3.

https://doi.org/10.1007/s13555-016-0152-3

Azfar NA, Khan AR, Zia MA, Humayun A, Malik LM, Jahangir M. Frequency of mucocutaneous manifestations in HIV positive Pakistani patients. J Pak Assoc Dermatol 2011; 21: 149–53.

Foroughi M, Koochak HE, Roosta N, Paydary K, Khatami A, Shahriari S et al. Prevalence of dermatologic manifestations among people living with HIV/AIDS in Imam Khomeini Hospital in Tehran, Iran.Journal of AIDS and HIV Research. 2012; 4(2): 56-9.

https://doi.org/10.5897/jahr11.056




DOI: http://dx.doi.org/10.24125/sanamed.v16i1.500

Refbacks

  • There are currently no refbacks.


Copyright (c) 2021 Milena Djurovic, Bogdanka Andric, Milica Đurović, Milos Bojic

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.